Latest news on Covid vaccine OK; Novartis' 1 win and 1 flop; Eli Lilly and the Alzheimer's puzzle; End of an era for Alnylam; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Endpoints News is firing on all cylinders. In this edition you will find some big news stories from the week, an in-depth feature, plenty of exclusive reporting and the first stories Beth Bulik has written for our brand new Pharma Marketing channel. Sign up to receive the first edition of her Endpoints MarketingRx newsletter next Tuesday — you won’t want to miss it.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.